We are live on ! Find out more
GOSS icon

Gossamer Bio

79 hedge funds and large institutions have $694M invested in Gossamer Bio in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 14

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

28% more call options, than puts

Call options by funds: $20M | Put options by funds: $15.7M

7.02% more ownership

Funds ownership: 55.68%62.7% (+7%)

7% more funds holding

Funds holding: 7479 (+5)

15% less capital invested

Capital invested by funds: $813M → $694M (-$119M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
79
Holders Change
+5
Holders Change %
+6.76%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
13
Increased
40
Reduced
14
Closed
7
Calls
$20M
Puts
$15.7M
Net Calls
+$4.34M
Net Calls Change
+$4.34M

GOSS Hedge Fund Activity: Q3 2019 in Review

79 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2019, worth a combined $694M — down 15% from $813M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GOSS positions and 7 closed out — a net gain of 6 holders — while 40 added to existing stakes and 14 trimmed.

The largest buyer was HHLR Advisors, adding an estimated $98.9M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $15.4M sold.

  • 79 institutional investors held Gossamer Bio (GOSS) as of Q3 2019, up from 74 in Q2 2019.
  • Funds reported $694M of Gossamer Bio stock for Q3 2019, down 15% quarter-over-quarter.
  • 13 funds opened new Gossamer Bio positions in Q3 2019 and 7 closed out, a net change of +6 holders.
  • The largest Gossamer Bio buyer in Q3 2019 was HHLR Advisors, an estimated $98.9M added.
  • The largest Gossamer Bio seller in Q3 2019 was EcoR1 Capital, an estimated $15.4M sold.

Based on aggregated 13F filings for Q3 2019.